Market Research Logo

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020)

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020)(By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

Executive Summary

Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease.

The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating role of private and government bodies in empowering R&D measures to avoid degenerative disorders. During 2015-20, Global Alzheimer Disease Market is anticipated to grow at an increased rate on account of robust expansion plans of the increase in medical facilities. Moreover, increase in number of patients suffering from degenerative disorder is further anticipated to boost the Global Alzheimer’s market in the coming years.

According to Azoth Analytics research report, “Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market)”, global Alzheimer’s market is projected to exhibit a CAGR of over 8.54% during 2015–2020. On the basis of Reisberg Scale, market is categorized by seven stages of Alzheimer. Alzheimer is expected to be cured by Drugs; Exercise and Nutrition. Growth in Alzheimer’s Drug market is anticipated to grow in the next five years. Asia Pacific region dominated the revenue contribution share in 2014 and the region is forecast to continue its domination through 2020. Few of the leading companies operating in Global Alzheimer’s Disease Market include Axovant Sciences Ltd., Biotie Therapies, Acadia Pharmaceuticals, Novartis International AG and many more.

Scope of the Report

The report “Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market)” analyzes the following aspects of global Alzheimer’s market:

  • Global Alzheimer’s Market Size, Share & Forecast
  • Segmental Analysis – By Therapeutics, By Diagnostics and Biomarkers, By Imaging Sector, By Patient and By Drugs
  • Policy & Regulatory Landscape
  • Market Entry Strategies for Domestic/Foreign Players
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations
Why You Should Buy This Report?

1. To gain an in-depth understanding of Alzheimer disease and dementia market propelling globally.

2. To identify the on-going trends and anticipated growth in the next five years

3. To help industry consultants, drug and diagnostics manufacturers, vendors and dealers align their market-centric strategies

4. To obtain research based business decision and add weight to presentations and marketing material

5. To gain competitive knowledge of leading players

6. To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific needs


1. Research Methodology
2. Alzheimer’s Disease Market Overview
3. Global Alzheimer’s Disease Market Outlook
4. Global Alzheimer’s Disease Market
4.1 By Therapeutics
4.2 By Diagnostics and Biomarkers
4.3 By Imaging Sector
4.4 By Disease Modifying Therapeutics
5. Global Alzheimer’s Disease Market Outlook-By Demographic (Age-Group)
6. Global Alzheimer’s Disease Market Outlook-By Drug
7. Global Alzheimer’s Disease Market Outlook-By Region
8. United States Alzheimer’s Disease Market Outlook
8.1 United States Dementia Market Outlook
9. Global Dementia Disease Market Outlook
10. Global Dementia Disease Market Outlook
10.1 By Regional Break-Up
10.1.1 Asia-Pacific Dementia Market Outlook
10.2 By Countries
10.2.1 Low Income Country -wise Break up
10.2.2 Top Ten Country-wise Break-Up
Australia Dementia Market Outlook
UK Dementia Market Outlook
11. Market Dynamics
11.1 Drivers
11.2 Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1 Sales Comparatives, Top 5 Companies
13.2 EBITDA Comparatives, Top 5 Companies
13.3 EBIT Comparatives, Top 5 Companies
13.4 PBT Comparatives, Top 5 Companies
13.5 PAT Comparatives, Top 5 Companies
13.6 Current Ratio Comparatives, Top 5 Companies
14. Company Profiling
14.1 Pfizer Inc.
14.2 Novartis International AG
14.3 Axovant Sciences Ltd.
14.4 Acadia Pharmaceuticals
14.5 Biotie Therapies
List of Figures
1. Global Alzheimer’s Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
2. Global Alzheimer’s Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
3. Global Alzheimer’s Market share, By Therapeutics
4. Global Alzheimer’s Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)
5. Global Alzheimer’s Disease Market, By Imaging Sector, By Value (USD Million)
6. Global Alzheimer’s Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USD Million)
7. Global Alzheimer’s Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in million),2010-2020F
8. Global Alzheimer’s Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in million),2010-2020F
9. Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
10. United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
11. Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
12. U.S. Alzheimer’s Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)
13. U.S. Alzheimer’s Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)
14. U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013
15. U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013
16. Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
17. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
18. Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In Million), By Region 2014
19. Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country 2015E,2030F,2050F
20. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
21. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
22. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
23. Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-2020F
24. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
25. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
26. UK Dementia Market, By Type, 2014 (%)
27. UK Dementia Cost, By Type of Service, 2014 (%)
28. Number of Unpaid Caregivers (In Million)
29. Pfizer Revenue (USD Million) AY 2011-2014
30. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
31. Pfizer Percentage Revenue, By Business Segment (2014)
32. Pfizer Percentage Revenue, By Geography (2014)
33. Novartis International AG Revenue (USD Million) AY 2011-2014
34. Novartis International AG Percentage Revenue, By Business Segment (2014)
35. Novartis International AG Percentage Revenue, By Geography (2014)
36. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
37. Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)
38. Axovant Services Ltd. Percentage Revenue, By Geography (2014)
39. Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014
40. Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)
41. Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)
42. Biotie Therapies Revenue (USD Million) AY 2011-2014
43. Biotie Therapies Percentage Revenue, By Business Segment (2014)
44. Sales Comparatives, Top 5 Companies, 2011-2014
45. EBITDA Comparatives, Top 5 Companies, 2011-2015
46. EBIT Comparatives, Top 5 Companies, 2011-2015
47. PBT Comparatives, Top 5 Companies, 2011-2015
48. PAT Comparatives, Top 5 Companies, 2011-2015
49. Current Ratio Comparatives, Top 5 Companies, 2011-2015
50. Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015
51. Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report